Welcome to PathPulse, the Digital Diagnostic podcast! In this episode, “Precision at the Point of Diagnosis: The Role of Genomic Tests in Personalized Pathology,” host James Thackeray is joined by…
Read More
Lumea and AIxMed team up to bring AI-driven urine cytology to Lumea’s platform, targeting improved bladder cancer diagnostics. LEHI, UT, UNITED STATES, May 27, 2025 /EINPresswire.com/ — Lumea, a leading…
Mopec Group, the industry leader of anatomic and forensic pathology equipment and technology, today announced a strategic partnership with Lumea, the leader in digital pathology and AI-powered workflow innovation–advancing efficient,…
The digital pathology landscape is evolving at an electrifying pace. As the industry matures, the pathways to tangible value and strategic revenue generation are becoming clearer. A recent article analyzing…
Lehi, Utah — May 13, 2025 — Lumea, a leader in digital pathology and workflow innovation, is pleased to announce the upcoming transition of the Chief Executive Officer role, which…
We’re excited to share that Lumea will be participating as a Technology Partner and Exhibitor at the upcoming Transforming Digital Pathology & AI: The Path Forward conference, taking place on…
The future of pathology isn’t just digital—it’s integrated. As precision medicine continues to advance, the need for seamless coordination between pathology and molecular diagnostics has never been greater. However, traditional…
A Summary of Staci Kearney’s presentation at the Digital Diagnostic Summit 2024 The Current State of the FDA’s Final Rule On May 6, 2024, the FDA issued its final rule…
AI has been a huge buzzword in pathology, but are the benefits worth the hype for prostate cancer? It’s true that AI can enhance digital prostate pathology by supporting diagnostic…
Laboratories worldwide are united by a commitment to excellence, whether in service, research, or the quality of their slides. However, beneath this shared dedication lies a diversity of resources, tools,…
